Amelioration of adjuvant-induced arthritis in CCDC134-overexpressing transgenic mice

Peng Xia,Tianzhuo Zhang,Xiaoting Gong,Lin Xiao,Qinyuan Liao,Xiaoyan Qiu,Jing Huang

DOI: https://doi.org/10.1016/j.bbrc.2017.05.166

IF: 3.1

2017-01-01

Biochemical and Biophysical Research Communications

Abstract:CCDC134 might be an immune cytokine and plays important and complex roles in the process in vivo. It was proved to illustrate its potent antitumor effects by augmenting CD8+ T-cell–mediated immunity, but its role in the development of rheumatoid arthritis (RA) remains unclear. In this study, we demonstrated that development of adjuvant-induced arthritis and pro-inflammatory responses were more ameliorated in CCDC134–overexpressing transgenic mice than those in WT mice. The underlying mechanism of CCDC134-induced effects involved inhibition of T helper (Th) 1 and Th17 cell differentiation. These findings indicate that overexpression of CCDC134 exerts potent anti-inflammatory effects through selective modulation of pathogenic Th1 and Th17 cells, and might provide insights into the role of CCDC134 as a unique therapeutic agent for the treatment of rheumatoid arthritis.